135 related articles for article (PubMed ID: 35768393)
21. Lesson of the month 2: Autoimmune sequelae of anti-GAD antibodies - thinking outside the box.
Ward RJ; Varughese GI; Jose B; Abraham RJ
Clin Med (Lond); 2017 Oct; 17(5):473-474. PubMed ID: 28974603
[TBL] [Abstract][Full Text] [Related]
22. Neurochondrin Antibody Serum Positivity in Three Cases of Autoimmune Cerebellar Ataxia.
Weihua Z; Haitao R; Fang F; Xunzhe Y; Jing W; Hongzhi G
Cerebellum; 2019 Dec; 18(6):1137-1142. PubMed ID: 31179511
[TBL] [Abstract][Full Text] [Related]
23. From dizziness to severe ataxia and dysarthria: New cases of anti-Ca/ARHGAP26 autoantibody-associated cerebellar ataxia suggest a broad clinical spectrum.
Wallwitz U; Brock S; Schunck A; Wildemann B; Jarius S; Hoffmann F
J Neuroimmunol; 2017 Aug; 309():77-81. PubMed ID: 28601293
[TBL] [Abstract][Full Text] [Related]
24. A Rare Case of Cerebellar Ataxia Due to Voltage-Gated Calcium Channel and Glutamic Acid Decarboxylase Autoantibodies.
Annunziata G; Lobo P; Carbuccia C
Am J Case Rep; 2017 Nov; 18():1251-1255. PubMed ID: 29176543
[TBL] [Abstract][Full Text] [Related]
25. Cerebellar ataxia with glutamic acid decarboxylase autoantibodies.
Abele M; Weller M; Mescheriakov S; Bürk K; Dichgans J; Klockgether T
Neurology; 1999 Mar; 52(4):857-9. PubMed ID: 10078741
[TBL] [Abstract][Full Text] [Related]
26. Immune Mediated Cerebellar Ataxia: An Unknown Manifestation of Graft-versus-Host Disease.
Shargian-Alon L; Raanani P; Rozovski U; Siegal T; Yust-Katz S; Yeshurun M
Acta Haematol; 2019; 141(1):19-22. PubMed ID: 30439710
[TBL] [Abstract][Full Text] [Related]
27. Anti-glutamic acid decarboxylase (GAD) positive cerebellar Ataxia with transitioning to progressive encephalomyelitis with rigidity and myoclonus (PERM), responsive to immunotherapy: A case report and review of literature.
Jazebi N; Rodrigo S; Gogia B; Shawagfeh A
J Neuroimmunol; 2019 Jul; 332():135-137. PubMed ID: 31015081
[TBL] [Abstract][Full Text] [Related]
28. Cerebellar ataxia and autoantibodies restricted to glutamic acid decarboxylase 67 (GAD67).
Guasp M; Solà-Valls N; Martínez-Hernández E; Gil MP; González C; Brieva L; Saiz A; Dalmau J; Graus F; Ariño H
J Neuroimmunol; 2016 Nov; 300():15-17. PubMed ID: 27806870
[TBL] [Abstract][Full Text] [Related]
29. GAD Antibody-Associated Late-Onset Cerebellar Ataxia in Two Female Siblings.
Kuchling J; Shababi-Klein J; Nümann A; Gerischer LM; Harms L; Prüss H
Case Rep Neurol; 2014 Sep; 6(3):264-70. PubMed ID: 25566057
[TBL] [Abstract][Full Text] [Related]
30. Autoimmune cerebellar ataxia with glutamic acid decarboxylase 65 antibodies associated with central vestibular symptoms.
London F; Hadhoum N; Zéphir H; Outteryck O; Vermersch P
Acta Neurol Belg; 2017 Sep; 117(3):775-776. PubMed ID: 27988832
[No Abstract] [Full Text] [Related]
31. Neurological disorders associated with glutamic acid decarboxylase 65 antibodies: Clinical spectrum and prognosis of a cohort from China.
Bai L; Ren H; Liang M; Lu Q; Lin N; Liu M; Fan S; Cui R; Guan H
Front Neurol; 2022; 13():990553. PubMed ID: 36277926
[TBL] [Abstract][Full Text] [Related]
32. [Cerebellar Ataxia and Autoantibodies].
Nanri K; Yoshikura N; Kimura A; Nakayama S; Otomo T; Shimohata T; Terashi H; Sato T; Yamada J
Brain Nerve; 2018 Apr; 70(4):371-382. PubMed ID: 29632285
[TBL] [Abstract][Full Text] [Related]
33. Clinical Characteristics and Management of 50 Patients with Anti-GAD Ataxia: Gluten-Free Diet Has a Major Impact.
Hadjivassiliou M; Sarrigiannis PG; Shanmugarajah PD; Sanders DS; Grünewald RA; Zis P; Hoggard N
Cerebellum; 2021 Apr; 20(2):179-185. PubMed ID: 33084997
[TBL] [Abstract][Full Text] [Related]
34. Epilepsy and cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies.
Vulliemoz S; Vanini G; Truffert A; Chizzolini C; Seeck M
J Neurol Neurosurg Psychiatry; 2007 Feb; 78(2):187-9. PubMed ID: 17229747
[TBL] [Abstract][Full Text] [Related]
35. Intravenous immunoglobulin therapy for autoantibody-positive cerebellar ataxia.
Nanri K; Okita M; Takeguchi M; Taguchi T; Ishiko T; Saito H; Otsuka T; Mitoma H; Koizumi K
Intern Med; 2009; 48(10):783-90. PubMed ID: 19443972
[TBL] [Abstract][Full Text] [Related]
36. Spontaneous downbeat nystagmus as a clue for the diagnosis of ataxia associated with anti-GAD antibodies.
Vale TC; Pedroso JL; Alquéres RA; Dutra LA; Barsottini OG
J Neurol Sci; 2015 Dec; 359(1-2):21-3. PubMed ID: 26671081
[TBL] [Abstract][Full Text] [Related]
37. Acute Cerebellar Ataxia Associated with Modest Elevation of Anti-GAD Antibodies in a Young Patient.
Gomez J; Jin D
Tremor Other Hyperkinet Mov (N Y); 2018; 8():620. PubMed ID: 30647991
[TBL] [Abstract][Full Text] [Related]
38. Cerebellar ataxia associated with anti-glutamic acid decarboxylase (anti-GAD) autoantibodies: a rare and puzzling disease.
Teive HA
Arq Neuropsiquiatr; 2017 Mar; 75(3):137-138. PubMed ID: 28355318
[No Abstract] [Full Text] [Related]
39. Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients.
Honnorat J; Saiz A; Giometto B; Vincent A; Brieva L; de Andres C; Maestre J; Fabien N; Vighetto A; Casamitjana R; Thivolet C; Tavolato B; Antoine J; Trouillas P; Graus F
Arch Neurol; 2001 Feb; 58(2):225-30. PubMed ID: 11176960
[TBL] [Abstract][Full Text] [Related]
40. [Pediatric autoimmune encephalitis associated with anti-glutamic acid decarboxylase 65 antibody: two cases report and literature review].
Ren CH; Ren HT; Ren XT; Zhang WH; Li JW; Dai LF; Chen CH; Guan HZ; Fang F
Zhonghua Er Ke Za Zhi; 2021 Jan; 59(1):47-52. PubMed ID: 33397004
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
